BIOGEN INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 218.1 USD | -3.17% |
|
-5.21% | -15.73% |
| May. 22 | US Equity Markets Close Down Wednesday After Fed Minutes Raise Inflation Concerns | MT |
| May. 22 | Sector Update: Health Care Stocks Slightly Higher Late Afternoon | MT |
ETFs positioned on Biogen Inc.
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.21% | 32 M€ | +0.48% | - | |
| 0.21% | 17 M€ | +4.82% | - | |
| 0.20% | 1,448 M€ | -.--% | - | |
| 0.20% | 219 M€ | +17.17% | - | |
| 0.20% | 50 M€ | +11.38% | ||
| 0.20% | 330 M€ | -.--% | ||
| 0.20% | 2 M€ | +14.69% | - | |
| 0.18% | 368 M€ | +22.78% | - | |
| 0.18% | 8 M€ | +7.26% | - | |
| 0.18% | 744 M€ | +10.58% | ||
| 0.18% | 276 M€ | +11.40% | - | |
| 0.18% | 273 M€ | -.--% | ||
| 0.18% | 655 M€ | -.--% | - | |
| 0.18% | 1,174 M€ | +23.54% | ||
| 0.17% | 36 M€ | +22.19% | ||
| 0.17% | 253 M€ | +6.93% | ||
| 0.16% | 26 M€ | +22.35% | - | |
| 0.15% | 2,383 M€ | +14.57% | ||
| 0.14% | 559 M€ | +14.30% | ||
| 0.14% | 1,848 M€ | +18.39% | - | |
| 0.13% | 1 M€ | +0.04% | ||
| 0.12% | 6 M€ | +17.98% | - | |
| 0.12% | 121 M€ | +7.84% | - | |
| 0.12% | 2 M€ | +5.51% | - | |
| 0.12% | 17 M€ | +4.66% | - | |
| 0.12% | 205 M€ | -.--% | ||
| 0.11% | 57 M€ | +22.31% | - | |
| 0.10% | 264 M€ | -.--% | - | |
| 0.10% | 187 M€ | +11.14% | - | |
| 0.10% | 477 M€ | +12.72% |
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
Pharmaceuticals
Calendar
2024-06-20
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
33
Last Close Price
218.1
USD
Average target price
287.3
USD
Spread / Average Target
+31.75%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -15.73% | 32.79B | |
| -2.11% | 89.22B | |
| +1.32% | 40.49B | |
| +64.13% | 26.23B | |
| -21.28% | 14.52B | |
| -8.50% | 13.09B | |
| -44.07% | 11.6B | |
| -13.06% | 11.5B | |
| +4.94% | 8.82B | |
| -17.66% | 7.92B |
- Stock Market
- Equities
- BIIB Stock
- Funds and ETFs Biogen Inc.
